Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications
The Danish company Novo says U.S.-based Lilly isn’t including the most up-to-date clinical information about its drugs.
Similar Posts
Items Retirees Can Sell To Build Fast Savings
stevecoleimages / Getty Images Commitment to Our Readers GOBankingRates’ editorial team is committed to bringing you unbiased reviews and information. We use data-driven methodologies to evaluate financial products and services – our reviews and ratings are not influenced by advertisers. You can read more about our editorial guidelines and our products and services review methodology….
What to Know About the $1,000 Emergency 401(k) Withdrawal
We research all brands listed and may earn a fee from our partners. Research and financial considerations may influence how brands are displayed. Not all brands are included. Learn more. If you have a legitimate emergency expense, you can tap into a 401(k) up to a certain amount without having to worry about the penalties…
Watch Fed Chairman Kevin Warsh testify live before Senate banking committee
[The stream is slated to start at 10 a.m. ET. CNBC Television will start the stream when the event begins. Please refresh the page if you do not see a player above.] Federal Reserve Chairman Kevin Warsh testifies Wednesday before the Senate Banking Committee, facing questions over the the economy and how various factors might…
Your Next Forever Stamp Purchase Will Soon Cost More. See the New Price
If your supply of Forever stamps is running low, you might want to restock now because the stamps will cost more soon. The U.S. Postal Service is raising the price of Forever stamps from 78 cents to 82 cents on Sunday, July 12. Overall, the Postal Service is raising mailing services product prices by about…
6 GLP-1 Risks That Hit Harder After 65 — Just As Medicare Starts Paying
Starting July 1, Medicare began covering weight-loss drugs like Wegovy and Zepbound for a $50 monthly copay. For seniors who’d been staring down price tags north of $1,000, that’s a real breakthrough. But here’s what most of the headlines skipped. These drugs don’t behave the same way in a 70-year-old body as they do in…
25-02624.pdf
25-02624.pdf Anonymous (not verified) Mon, 07/20/2026 – 10:40 Case ID 25-02624 Forum FINRA Document Type Award Claimants Oybek Giyazov Respondents Wells Fargo Clearing Services, LLC Neutrals Gregory D. Hoffmann Susan L. Luck Evalyn Lipton Fishbein Hearing Site Los Angeles, CA Award Document 25-02624.pdf Documentum DocID c30cc25c Award Date Official Fri, 07/17/2026 – 12:00 Related Content…
